Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Insights and Forecast to 2028

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (Above or equal to 65)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
2.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales 23-Valent Pneumococcal Polysaccharide Vaccine by Region (2023-2028)
2.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers
3.1.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine in 2021
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2021
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type
4.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2017-2022)
4.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application
5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application
5.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2017-2022)
5.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
6.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
6.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
6.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
6.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
6.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
6.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
6.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)
6.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
7.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
7.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
7.3.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)
7.3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
8.1.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
8.2.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
8.3.1 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
9.1.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
9.1.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
9.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
9.2.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
9.2.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
9.3 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
9.3.1 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)
9.3.2 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
10.1.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
10.2.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
10.3.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 MSD
11.1.1 MSD Corporation Information
11.1.2 MSD Overview
11.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 MSD Recent Developments
11.2 Sanofipasteur
11.2.1 Sanofipasteur Corporation Information
11.2.2 Sanofipasteur Overview
11.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofipasteur Recent Developments
11.3 CDIBP
11.3.1 CDIBP Corporation Information
11.3.2 CDIBP Overview
11.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CDIBP Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Chain Analysis
12.2 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 23-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
12.4 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Marketing
12.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channels
12.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
12.5 23-Valent Pneumococcal Polysaccharide Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
13.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
13.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
13.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
14 Key Findings in The Global 23-Valent Pneumococcal Polysaccharide Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Single Dose Vial
Table 3. Major Manufacturers of Pre-filled Syringe
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Dose)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Dose)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2017-2022) & (K Dose)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturers (2017-2022) &(US$/Dose)
Table 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2021)
Table 21. 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 23. Date of Manufacturers Enter into 23-Valent Pneumococcal Polysaccharide Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2017-2022)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2023-2028)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2017-2022)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2023-2028)
Table 33. 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2017-2022) & (US$/Dose)
Table 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2023-2028) & (US$/Dose)
Table 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2017-2022)
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2023-2028)
Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2017-2022)
Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2023-2028)
Table 43. 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2017-2022) & (US$/Dose)
Table 44. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2023-2028) & (US$/Dose)
Table 45. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 46. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
Table 47. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 50. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
Table 51. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 54. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Dose)
Table 55. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 58. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
Table 59. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 62. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
Table 63. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 66. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Dose)
Table 67. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 70. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
Table 71. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 74. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
Table 75. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Dose)
Table 78. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Dose)
Table 79. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 82. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
Table 83. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 86. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
Table 87. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 90. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Dose)
Table 91. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Dose)
Table 94. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Dose)
Table 95. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Dose)
Table 98. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Dose)
Table 99. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Dose)
Table 102. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Dose)
Table 103. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. MSD Corporation Information
Table 106. MSD Description and Major Businesses
Table 107. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 108. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. MSD Recent Developments
Table 110. Sanofipasteur Corporation Information
Table 111. Sanofipasteur Description and Major Businesses
Table 112. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 113. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Sanofipasteur Recent Developments
Table 115. CDIBP Corporation Information
Table 116. CDIBP Description and Major Businesses
Table 117. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
Table 118. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. CDIBP Recent Developments
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 123. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 124. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Table 125. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
Table 126. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 127. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type in 2021 & 2028
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2021 & 2028
Figure 6. For Children (2-10)
Figure 7. For Person (10-64)
Figure 8. For The Old (Above or equal to 65)
Figure 9. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2017-2028 (K Dose)
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2017-2028 (US$ Million)
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
Figure 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2023-2028)
Figure 16. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2017-2028) & (K Dose)
Figure 17. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2017-2028) & (K Dose)
Figure 19. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2017-2028) & (K Dose)
Figure 21. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2017-2028) & (K Dose)
Figure 23. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales YoY (2017-2028) & (K Dose)
Figure 25. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine in the World: Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2021
Figure 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
Figure 33. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 34. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
Figure 35. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 36. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
Figure 37. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2017-2028)
Figure 38. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2017-2028)
Figure 39. U.S. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 42. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
Figure 43. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
Figure 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country (2017-2028)
Figure 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Country (2017-2028)
Figure 47. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific 23-Valent Pneumococcal Polysaccharide V

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs